Cite
HARVARD Citation
Dupont, B. et al. (n.d.). Utility of serum anti‐cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab. British journal of clinical pharmacology. pp. 623-631. [Online].